Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de nov...
Manufactured by
Lepu Medical (Europe) Inc. Coöperatief U.A
Heerenveen, Netherlands
Lepu Medical Technology (Beijing) Co., Ltd., established in 1999, is one of China's earliest enterprises engaged in the research and development of interventional cardiology medical devices. In 2009, Lepu Medical was successfully listed on the Shenzhen Stock Exchange s Growth Enterprise Market (Stock Code: 300003). In 2022, Lepu Medical was also listed on the Swiss Stock Exchange (ISIN: US52678P2056). Our two subsidiaries, LEPU BIOPHARMA and Scientech, are also listed on the Hong Kong Stock Exchange.
© 2026 Suplivia · Home · Browse Products